Management of a patient with lupus anticoagulant and antiphospholipid syndrome for off-pump coronary artery bypass grafting using the hepcon® system

Anesthesia and Analgesia

Volumn 108, Issue 4, 2009, Pages 1116-1119

  Jervis, Karinne ^a   Senthilnathan, Venkatachalam ^a   Lerner, Adam B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTITHROMBIN III; CLONIDINE; HEPARIN; ISOSORBIDE; LISINOPRIL; LUPUS ANTICOAGULANT; PROTAMINE; WARFARIN; ANTICOAGULANT AGENT;

AGED; ANESTHESIA INDUCTION; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTERIOVENOUS FISTULA; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; FEMALE; GENERAL ANESTHESIA; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; NEUTROPENIA; OFF PUMP CORONARY SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTOPENIA; THROMBOPLASTIN TIME; THROMBOSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; UNSTABLE ANGINA PECTORIS; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; DRUG EFFECT; DRUG MONITORING; IMMUNOLOGY; INSTRUMENTATION; PEROPERATIVE CARE; REVIEW; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY ARTERY DISEASE; DRUG MONITORING; FEMALE; HEPARIN; HUMANS; INTRAOPERATIVE CARE; LUPUS COAGULATION INHIBITOR; TREATMENT OUTCOME;

EID: 63849254899     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181994f88     Document Type: Article

References (26)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, PG, DEG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306
2. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11
3. Park KW. The antiphospholipid syndrome. Int Anesthesiol Clin 2004;42:45-57
4. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med 1990;20:231-6
5. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63
6. Schultz DR. Antiphospholipid antibodies: basic immunology and assays. Semin Arthritis Rheum 1997;26:724-39
7. Massoudy P, Cetin SM, Thielmann M, Kienbaum P, Piotrowski JA, Marggraf G, Specker C, Jakob H. Antiphospholipid syndrome in cardiac surgery-an underestimated coagulation disorder? Eur J Cardiothorac Surg 2005;28:133-7
8. Ciocca RG, Choi J, Graham AM. Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg 1995;170:198-200
9. Gorki H, Malinovski V, Stanbridge RD. The antiphospholipid syndrome and heart valve surgery. Eur J Cardiothorac Surg 2008;33:168-81
10. Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T. Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1996;80:16-22
11. Baca V, Montiel G, Meillon L, Pizzuto J, Catalan T, Juan-Shum L, Nieva B. Diagnosis of lupus anticoagulant in the lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature. Am J Hematol 2002;71:200-7
12. Vivaldi P, Rossetti G, Galli M, Finazzi G. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Haematologica 1997;82:345-7
13. East CJ, Clements F, Mathew J, Slaughter TF. Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients. Anesth Analg 2000;90:1098-101
14. Despotis GJ, Joist JH, Hogue CW Jr, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1995;110:46-54
15. Ducart AR, Collard EL, Osselaer JC, Broka SM, Eucher PM, Joucken KL. Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant. J Cardiothorac Vasc Anesth 1997;11:878-9
16. Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 1998;87:781-5
17. Murray DJ, Brosnahan WJ, Pennell B, Kapalanski D, Weiler JM, Olson J. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth 1997;11:24-8
18. Raymond PD, Ray MJ, Callen SN, Marsh NA. Heparin monitoring during cardiac surgery. I. Validation of whole-blood heparin concentration and activated clotting time. Perfusion 2003;18:269-76
19. Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Spitznagel E, Cox JL, Lappas DG. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg 1994;108:1076-82
20. Hardy JF, Belisle S, Robitaille D, Perrault J, Roy M, Gagnon L. Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X. J Thorac Cardiovasc Surg 1996;112:154-61
21. Wang JS, Lin CY, Karp RB. Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients. Anesth Analg 1994;79:9-13
22. Fahy BG, Malinow AM. Anesthesia with antiphospholipid antibodies: anesthetic management of a parturient with lupus anticoagulant and anticardiolipin antibody. J Clin Anesth 1996;8:49-53
23. Englberger L, Streich M, Tevaearai H, Carrel TP. Different anticoagulation strategies in off-pump coronary artery bypass operations: a European survey. Interact Cardiovasc Thorac Surg 2008;7:378-82
24. Mariani MA, Gu YJ, Boonstra PW, Grandjean JG, van Oeveren W, Ebels T. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? Ann Thorac Surg 1999;67:1370-5
25. Tanaka KA, Thourani VH, Williams WH, Duke PG, Levy JH, Guyton RA, Puskas JD. Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. J Anesth 2007;21:297-303
26. Sheikh F, Lechowicz A, Setlur R, Rauch A, Dunn H. Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1997;11:764-6